Figure 3
From: Pathway-gene identification for pancreatic cancer survival via doubly regularized Cox regression
Logrank test of the long- and short-survival groups based on the 4 pathways and 15 genes (p-value = 0.0179). The 102 PDAC patients are divided into long- and short-survival groups based on the 4 pathways and 15 genes. The survival probabilities of these two groups are compared using the logrank test. The p-value of 0.0179 means the two groups are well separated and our finding of 4 pathways and 15 genes is significant.